ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

REFERENCES

• Al-Khodairy, F., E. Fotou, K. S. Sheldrick, D. J. F. Griffiths, A. R. Lehmann, and A. M. Carr. 1994. Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell 5:147–160.
   PubMed Web of Science ®Google Scholar
• Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677.
   PubMed Web of Science ®Google Scholar
• Blasina, A., B. D. Price, G. A. Turenne, and C. H. McGowan. 1999. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1135–1138.
   PubMed Web of Science ®Google Scholar
• Boddy, M. N., B. Furnari, O. Mondesert, and P. Russell. 1998. Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280:909–912.
   PubMed Web of Science ®Google Scholar
• Brown, A., C.-H. Lee, J. K. Schwarz, N. Mitiku, D. Griffith, H. Piwnica-Worms, and J. H. Chung. 1999. A human Cds1-related kinase that functions downstream of ATM in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 96:3745–3750.
   PubMedGoogle Scholar
• Brown, E. J., and D. Baltimore. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397–402.
   PubMed Web of Science ®Google Scholar
• Busby, E. C., D. F. Leistritz, R. T. Abraham, L. M. Karnitz, and J. N. Sarkaria. 2000. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res. 60:2108–2212.
   PubMed Web of Science ®Google Scholar
• Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1689.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, P., W. K. Eng, Y. Zhu, M. R. Mattern, R. Mishra, M. R. Hurle, X. Zhang, R. S. Annan, Q. Lu, L. F. Faucette, G. F. Scott, X. Li, S. A. Carr, R. K. Johnson, J. D. Winkler, and B.-B. S. Zhou. 1999. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18:4047–4054.
   PubMed Web of Science ®Google Scholar
• Chehab, N. H., A. Malikzay, E. S. Stavridi, and T. D. Halazonetis. 1999. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:13777–13782.
   PubMed Web of Science ®Google Scholar
• Chen, A. Y., and L. F. Liu. 1994. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191–218.
   PubMed Web of Science ®Google Scholar
• Chen, P., C. Luo, Y. Deng, K. Ryan, J. Register, S. Margosiak, A. Tempczyk-Russell, B. Nguyen, P. Myers, K. Lundgren, C. C. Kan, and P. M. O'Connor. 2000. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100:681–692.
   PubMed Web of Science ®Google Scholar
• Cimprich, K. A., T. B. Shin, C. T. Keith, and S. L. Schreiber. 1996. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA 93:2850–2855.
   PubMed Web of Science ®Google Scholar
• Cliby, W. A., C. J. Roberts, K. A. Cimprich, C. M. Stringer, J. R. Lamb, S. L. Schreiber, and S. H. Friend. 1998. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17:159–169.
   PubMed Web of Science ®Google Scholar
• Cortez, D., Y. Wang, J. Qin, and S. J. Elledge. 1999. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286:1162–1166.
   PubMed Web of Science ®Google Scholar
• Dalal, S. N., C. M. Schweitzer, J. Gan, and J. A. DeCaprio. 1999. Cytoplasmic localization of human cdc25C during interphase requires an intact 14–3-3 binding site. Mol. Cell. Biol. 19:4465–4479.
   PubMed Web of Science ®Google Scholar
• de Klein, A., M. Muijtjens, R. van Os, Y. Verhoeven, B. Smit, A. M. Carr, A. R. Lehmann, and J. H. Hoeijmakers. 2000. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10:479–482.
   PubMed Web of Science ®Google Scholar
• Downes, C. S., D. J. Clarke, A. M. Mullinger, J. F. Gimenez-Abian, A. M. Creighton, and R. T. Johnson. 1994. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372:467–470.
   PubMed Web of Science ®Google Scholar
• Eastman, A.. 1987. The formation, isolation and characterization of DNA adducts by the anti-cancer platinum complexes. Pharmacol. Ther. 34:155–166.
   PubMed Web of Science ®Google Scholar
• Flaggs, G., A. W. Plug, K. M. Dunks, K. E. Mundt, J. C. Ford, M. R. E. Quiggle, E. M. Taylor, C. H. Westphal, T. Ashley, M. F. Hoekstra, and A. M. Carr. 1997. ATM-dependent interactions of a mammalian Chk1 homolog with meiotic chromosomes. Curr. Biol. 7:977–986.
   PubMedGoogle Scholar
• Fogarty, P., S. D. Campbell, R. Abu-Shumays, B. S. Phalle, K. R. Yu, G. L. Uy, M. L. Goldberg, and W. Sullivan. 1997. The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity. Curr. Biol. 7:418–426.
   PubMed Web of Science ®Google Scholar
• Francesconi, S., M. Grenon, D. Bouvier, and G. Baldacci. 1997. p56chk1 protein kinase is required for the DNA replication checkpoint at 37oC in fission yeast. EMBO J. 16:1332–1341.
   PubMedGoogle Scholar
• Gatei, M., S. P. Scott, I. Filippovitch, N. Soronika, M. F. Lavin, B. Weber, and K. K. Khanna. 2000. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60:3299–3304.
   PubMed Web of Science ®Google Scholar
• Graves, P. R., C. M. Lovly, G. L. Uy, and H. Piwnica-Worms. 2001. Localization of human Cdc25C is regulated both by nuclear export and 14–3-3 binding. Oncogene 20:1839–1851.
   PubMedGoogle Scholar
• Graves, P. R., L. Yu, J. K. Schwarz, J. Gales, E. A. Sausville, P. M. O'Connor, and H. Piwnica-Worms. 2000. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275:5600–5605.
   PubMed Web of Science ®Google Scholar
• Guo, Z., A. Kumagai, S. X. Wang, and W. G. Dunphy. 2000. Requirement for atr in phosphorylation of chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 14:2745–2756.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629–634.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Jackson, J. R., A. Gilmartin, C. Imburgia, J. D. Winkler, L. A. Marshall, and A. Roshak. 2000. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res. 60:566–572.
   PubMed Web of Science ®Google Scholar
• Kaneko, Y. S., N. Watanabe, H. Morisaki, H. Akita, A. Fujimoto, K. Tominaga, M. Terasawa, A. Tachibana, K. Ikeda, M. Nakanishi, and Y. Kaneko. 1999. Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene 18:3673–3681.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., and D.-S. Lim. 2000. The many substrates and functions of ATM. Nat. Rev. 1:179–186.
   Google Scholar
• Keegan, K. S., D. A. Holtzman, A. W. Plug, E. R. Christenson, E. E. Brainerd, G. Flaggs, N. J. Bentley, E. M. Taylor, M. S. Meyn, S. B. Moss, A. M. Carr, T. Ashley, and M. F. Hoekstra. 1996. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev. 10:2423–2437.
   PubMed Web of Science ®Google Scholar
• Khanna, K. K., K. E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, and S. P. Lees-Miller. 1999. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20:398–400.
   Google Scholar
• Khosravi, R., R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy. 2000. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:14973–14977.
   Google Scholar
• Kim, S. T., D. S. Lim, C. E. Canman, and M. B. Kastan. 1999. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:37538–37543.
   PubMed Web of Science ®Google Scholar
• Kumagai, A., and W. G. Dunphy. 1999. Binding of 14–3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 13:1067–1072.
   PubMedGoogle Scholar
• Kumagai, A., and W. G. Dunphy. 2000. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol. Cell 6:839–849.
   PubMed Web of Science ®Google Scholar
• Kumagai, A., Z. Guo, K. H. Emami, S. X. Wang, and W. G. Dunphy. 1998. The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J. Cell Biol. 142:1559–1569.
   PubMed Web of Science ®Google Scholar
• Kumagai, A., P. S. Yakowec, and W. G. Dunphy. 1998. 14–3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol. Biol. Cell 9:345–354.
   PubMedGoogle Scholar
• Lakin, N. D., B. C. Hann, and S. P. Jackson. 1999. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene 18:3989–3995.
   PubMed Web of Science ®Google Scholar
• Li, S., N. S. Ting, L. Zheng, P. L. Chen, Y. Ziv, Y. Shiloh, E. Y. Lee, and W. H. Lee. 2000. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406:210–215.
   PubMed Web of Science ®Google Scholar
• Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613–617.
   PubMed Web of Science ®Google Scholar
• Lindsay, H. D., D. J. Griffiths, R. J. Edwards, P. U. Christensen, J. M. Murray, F. Osman, N. Walworth, and A. M. Carr. 1998. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe. Genes Dev. 12:382–395.
   PubMed Web of Science ®Google Scholar
• Liu, Q., S. Guntuku, X. S. Cui, S. Matsuoka, D. Cortez, K. Tamai, G. Luo, S. Carattini-Rivera, F. DeMayo, A. Bradley, L. A. Donehower, and S. J. Elledge. 2000. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14:1448–1459.
   PubMed Web of Science ®Google Scholar
• Lopez-Girona, A., B. Furnari, O. Mondesert, and P. Russell. 1999. Nuclear localization of Cdc25 is regulated by DNA damage and a 14–3-3 protein. Nature 397:172–175.
   PubMedGoogle Scholar
• Mailand, N., J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas. 2000. Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425–1429.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. J. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97:10389–10394.
   PubMed Web of Science ®Google Scholar
• Mikita, T., and G. P. Beardsley. 1988. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry 27:4698–4705.
   PubMed Web of Science ®Google Scholar
• Moser, B. A., J.-M. Brondello, B. Baber-Furnari, and P. Russell. 2000. Mechanism of caffeine-induced checkpoint override in fission yeast. Mol. Cell. Biol. 20:4288–4294.
   PubMed Web of Science ®Google Scholar
• Nakajo, N., T. Oe, K. Uto, and N. Sagata. 1999. Involvement of Chk1 kinase in prophase I arrest of Xenopus oocytes. Dev. Biol. 207:432–444.
   PubMed Web of Science ®Google Scholar
• Oe, T., N. Nakajo, Y. Katsuragi, K. Okazaki, and N. Sagata. 2001. Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes. Dev. Biol. 229:250–261.
   PubMedGoogle Scholar
• O'Neill, T., A. J. Dwyer, Y. Ziv, D. W. Chan, S. P. Lees-Miller, R. H. Abraham, J. H. Lai, D. Hill, Y. Shiloh, L. C. Cantley, and G. A. Rathbun. 2000. Utilization of orientated peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275:22719–22727.
   PubMed Web of Science ®Google Scholar
• Peng, C. Y., P. R. Graves, S. Ogg, R. S. Thoma, M. J. Byrnes III, Z. Wu, M. T. Stephenson, and H. Piwnica-Worms. 1998. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14–3-3 protein binding. Cell Growth Differ. 9:197–208.
   PubMedGoogle Scholar
• Peng, C. Y., P. R. Graves, R. S. Thoma, Z. Wu, A. S. Shaw, and H. Piwnica-Worms. 1997. Mitotic and G2 checkpoint control: regulation of 14–3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501–1505.
   PubMed Web of Science ®Google Scholar
• Sanchez, Y., J. Bachant, H. Wang, F. Hu, D. Liu, M. Tetzlaff, and S. J. Elledge. 1999. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science 286:1166–1171.
   PubMed Web of Science ®Google Scholar
• Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497–1501.
   PubMed Web of Science ®Google Scholar
• Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:4375–4382.
   PubMed Web of Science ®Google Scholar
• Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D. A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S. R. Patanjali, A. Simmons, G. A. Clines, A. Sartiel, R. A. Gatti, L. Chessa, O. Sanal, M. F. Lavin, N. G. J. Jaspers, A. M. R. Taylor, C. F. Arlett, T. Miki, S. M. Weissman, M. Lovett, F. S. Collins, and Y. Shiloh. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749–1753.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136.
   PubMed Web of Science ®Google Scholar
• Sibon, O. C. M., V. A. Stevenson, and W. E. Theurkauf. 1997. DNA-replication checkpoint control at the Drosophila midblastula transition. Nature 388:93–97.
   PubMed Web of Science ®Google Scholar
• Takai, H., K. Tominaga, N. Motoyama, Y. A. Minamishima, H. Nagahama, T. Tsukiyama, K. Ikeda, K. Nakayama, M. Nakanishi, and K. Nakayama. 2000. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(−/−) mice. Genes Dev. 14:1439–1447.
   PubMed Web of Science ®Google Scholar
• Tibbetts, R. S., K. M. Brumbaugh, J. M. Williams, J. N. Sarkaria, W. A. Cliby, S. Y. Shieh, Y. Taya, C. Prives, and R. T. Abraham. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152–157.
   PubMed Web of Science ®Google Scholar
• Tibbetts, R. S., D. Cortez, K. M. Brumbaugh, R. Scully, D. Livingston, S. J. Elledge, and R. T. Abraham. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2989–3002.
   PubMed Web of Science ®Google Scholar
• Townsend, A. J., and Y.-C. Cheng. 1987. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template. Mol. Pharmacol. 32:330–339.
   PubMed Web of Science ®Google Scholar
• van der Geer, P., and T. Hunter. 1994. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis 15:544–554.
   PubMed Web of Science ®Google Scholar
• Walworth, N., S. Davey, and D. Beach. 1993. Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363:368–371.
   PubMed Web of Science ®Google Scholar
• Walworth, N. C., and R. Bernards. 1996. rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 271:353–356.
   PubMed Web of Science ®Google Scholar
• Wright, J. A., K. S. Keegan, D. R. Herendeen, N. J. Bentley, A. M. Carr, M. F. Hoekstra, and P. Concannon. 1998. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc. Natl. Acad. Sci. USA 95:7445–7450.
   PubMed Web of Science ®Google Scholar
• Wu, X., V. Ranganathan, D. S. Weisman, W. F. Heine, D. N. Ciccone, T. B. O'Neil, K. E. Crick, K. S. Pierce, W. S. Lane, G. Rathbun, D. M. Livingston, and D. T. Weaver. 2000. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477–482.
   PubMed Web of Science ®Google Scholar
• Yang, J., K. Wonkler, M. Yoshida, and S. Kornbluth. 1999. Maintenance of G2 arrest in the Xenopus oocyte: a role for 14–3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 18:2174–2183.
   PubMed Web of Science ®Google Scholar
• Yin, M. B., B. Guo, U. Vanhoefer, R. G. Azrak, H. Minderman, C. Frank, C. Wrzosek, H. K. Slocum, and Y. M. Rustum. 2000. Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350. Mol. Pharmacol. 57:453–459.
   PubMedGoogle Scholar
• Zeng, Y., K. C. Forbes, Z. Wu, S. Moreno, H. Piwnica-Worms, and T. Enoch. 1998. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395:507–510.
   PubMedGoogle Scholar
• Zeng, Y., and H. Piwnica-Worms. 1999. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14–3-3 binding. Mol. Cell. Biol. 19:7410–7419.
   PubMed Web of Science ®Google Scholar
• Zhao, S., Y.-C. Weng, S.-S. F. Yuan, Y.-T. Lin, H. C. Hsu, S.-C. Lin, E. Gerbino, M.-H. Song, M. Z. Zdzienicka, R. A. Gatti, J. W. Shay, Y. Ziv, Y. Shiloh, and E. Y.-H. P. Lee. 2000. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405:473–477.
   PubMed Web of Science ®Google Scholar
• Zhou, B. B., P. Chaturvedi, K. Spring, S. P. Scott, R. A. Johanson, R. Mishra, M. R. Mattern, J. D. Winkler, and K. K. Khanna. 2000. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275:10342–10348.
   PubMed Web of Science ®Google Scholar
• Zhou, B. B., and S. J. Elledge. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433–439.
   PubMed Web of Science ®Google Scholar
• Ziv, Y., A. Bar-Shira, I. Pecker, P. Russell, T. J. Jorgensen, I. Tsarfati, and Y. Shiloh. 1997. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15:159–167.
   PubMed Web of Science ®Google Scholar